Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 160 (1) , 141-146
- https://doi.org/10.1016/s0021-9150(01)00545-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivoJournal of Laboratory and Clinical Medicine, 2000
- Induction of heat shock protein 70 protects mesangial cells against oxidative injuryKidney International, 1999
- Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathyKidney International, 1999
- Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patientsDiabetes Research and Clinical Practice, 1999
- Oxidative Modification of Low-Density Lipoprotein Enhances Mesangial Cell Protein Synthesis and Gene Expression of Extracellular Matrix ProteinsAmerican Journal of Nephrology, 1998
- Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patientsKidney International, 1997
- The many masks of focal segmental glomerulosclerosisKidney International, 1994
- Lipid advanced glycosylation: pathway for lipid oxidation in vivo.Proceedings of the National Academy of Sciences, 1993
- Decreased Albuminuria by Pravastatin in Hyperlipidemic DiabeticsNephron, 1991
- Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus.Japanese Journal of Medicine, 1990